Olfr963, a member of the olfactory receptor family 1 subfamily K, is crucial in the olfactory system of Mus musculus, functioning as a G-protein-coupled receptor (GPCR). These receptors are essential for detecting and transducing odorant molecules, leading to the perception of smell. Olfr963, characterized by a 7-transmembrane domain structure, binds to odorant molecules, initiating a cascade of intracellular events that culminate in a neuronal response. This specific ability to bind and signal is key to the olfactory system's capacity to differentiate a wide range of scents. The inhibition of Olfr963's function can be achieved through both direct and indirect methods. Direct inhibition would entail blocking the interaction of the receptor with odorant molecules, thereby halting the activation of the associated G-protein and subsequent signal transduction. Achieving this specificity is crucial to prevent unintended effects on other GPCRs. Indirect inhibition, on the other hand, involves broader strategies such as affecting the receptor's membrane dynamics, conformation, or influencing related signaling pathways. This can include altering receptor membrane composition, which affects its ability to bind ligands, or targeting downstream signaling pathways that regulate receptor desensitization, internalization, or recycling, thereby modulating its activity. The chemicals listed in the table exemplify potential indirect inhibitors of Olfr963, each acting through distinct mechanisms like cytochrome P450 enzyme inhibition, modulation of neurotransmitter receptors, or alteration of G-protein coupling.
Understanding the mechanisms of Olfr963's function and inhibition is critical for elucidating the complex dynamics of olfactory transduction. Exploring both direct and indirect inhibitory strategies offers valuable insights into the modulation of GPCR activity, especially within the context of olfactory receptors. This knowledge not only enhances our understanding of olfactory perception but also contributes to the broader field of GPCR research, which has significant implications in sensory biology and pharmacology. Investigating inhibitors of Olfr963 and similar receptors is vital for developing a comprehensive understanding of the molecular dynamics governing olfactory signaling and the potential for targeted modulation of these processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fluconazole | 86386-73-4 | sc-205698 sc-205698A | 500 mg 1 g | $53.00 $84.00 | 14 | |
Fluconazole, an antifungal agent, inhibits fungal cytochrome P450 enzymes, impacting steroid biosynthesis. It could indirectly affect GPCR function, including olfactory receptors like Olfr963, by altering cell membrane dynamics. | ||||||
Fexofenadine | 83799-24-0 | sc-218475 | 100 mg | $292.00 | 1 | |
Fexofenadine, a selective H1 antihistamine, indirectly modulates GPCR signaling. By inhibiting histamine action, it reduces the modulation of GPCR activity, potentially decreasing Olfr963 signaling in olfactory pathways. | ||||||
Metoprolol Tartrate | 56392-17-7 | sc-205751 sc-205751A | 5 g 25 g | $105.00 $238.00 | 3 | |
Metoprolol, a selective beta-1 adrenergic receptor blocker, affects GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr963 function. | ||||||
Desipramine hydrochloride | 58-28-6 | sc-200158 sc-200158A | 100 mg 1 g | $65.00 $115.00 | 6 | |
Desipramine, a tricyclic antidepressant with histamine and serotonin antagonist properties, affects GPCR modulation. This can indirectly impact the signaling of receptors like Olfr963 by altering the GPCR milieu. | ||||||
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $77.00 $408.00 | 1 | |
Atenolol, a selective beta-1 adrenergic receptor blocker, modulates GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr963 function. | ||||||
Lansoprazole | 103577-45-3 | sc-203101 sc-203101A | 500 mg 1 g | $58.00 $173.00 | 6 | |
Lansoprazole, a proton pump inhibitor, can indirectly modulate GPCR activity. By affecting gastric acid secretion, it impacts the histamine-mediated modulation of GPCRs, potentially affecting Olfr963 signaling. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $122.00 $235.00 $520.00 $979.00 $1500.00 | 2 | |
Carvedilol, a non-selective beta and alpha-1 adrenergic blocker, affects GPCR signaling indirectly. By blocking these receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr963 function. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil, a calcium channel blocker, can influence GPCR function indirectly. By modulating calcium influx, it affects GPCR-mediated signaling, potentially impacting receptors like Olfr963. | ||||||